Nav: Home

Bacteria take a deadly risk to survive

May 02, 2017

Bacteria need mutations -- changes in their DNA code -- to survive under difficult circumstances. When necessary, they can even mutate at different speeds. This is shown in a recent study by the Centre of Microbial and Plant Genetics at KU Leuven (University of Leuven), Belgium. The findings open up various new avenues for research, ranging from more efficient biofuel production methods to a better treatment for bacterial infections and cancer.

When they're under stress, bacteria start mutating to produce one or more DNA variants that make it possible for the bacteria to survive and reproduce. But mutating is dangerous under normal circumstances as it weakens the bacteria. The trick, therefore, is finding the balance between too many and too few mutations. Losing this balance means hypermutation: the cell mutates much more quickly than it normally does, eventually leading to death.

As scientific knowledge about the role of hypermutation is still limited, KU Leuven researchers examined its underlying mechanism in the gut bacteria Escherichia coli. "E.coli is a notorious cause of diarrhoea, but most E.coli strains are in fact harmless gut bacteria found in human beings and animals," says Professor Jan Michiels. "Exposure to high, near-lethal concentrations of ethanol triggers hypermutation in the E.coli. We were surprised to find that the speed of hypermutation in the bacteria can rapidly be changed: the bacteria mutate more quickly in higher concentrations of ethanol and more slowly when the ethanol stress is relieved. As soon as the danger is past, the bacteria step on the brake and try to revert to their normal state, without hypermutation."

Hypermutation allowed the bacteria to survive ethanol stress and enabled the researchers to select E. coli mutants that are very resistant to ethanol. This offers new perspectives for research on biofuel production. "In the biofuel production process sugar is derived from plant residues and similar waste products. This sugar, in turn, is converted into ethanol. E.coli bacteria can be used for this purpose: they can convert sugars into ethanol but are eventually killed by the ethanol they produce. The hypermutation enabled us to obtain variants that are less susceptible to ethanol and that grow quickly. This means that we might be able to use them for more efficient biofuel production."

"Another application is the fight against the antibiotic resistance of bacteria and the resistance of cancer cells to chemotherapy," doctoral student Toon Swings adds. "Antibiotics pose a deadly threat to bacteria. The bacteria protect themselves by mutating and, as a result, they develop antibiotic resistance. The same applies to cancer cells after a treatment. Therefore, blocking hypermutation could form a possible treatment or perhaps even a new co-therapy."
-end-


KU Leuven

Related Cancer Articles:

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
More Cancer News and Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Speedy Beet
There are few musical moments more well-worn than the first four notes of Beethoven's Fifth Symphony. But in this short, we find out that Beethoven might have made a last-ditch effort to keep his music from ever feeling familiar, to keep pushing his listeners to a kind of psychological limit. Big thanks to our Brooklyn Philharmonic musicians: Deborah Buck and Suzy Perelman on violin, Arash Amini on cello, and Ah Ling Neu on viola. And check out The First Four Notes, Matthew Guerrieri's book on Beethoven's Fifth. Support Radiolab today at Radiolab.org/donate.